CG Oncology CGON Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's short-term investments?
- CG Oncology (CGON) reported short-term investments of $1.04B in Q1 2026.
- How has CG Oncology's short-term investments changed year-over-year?
- CG Oncology's short-term investments increased by 61.1% year-over-year, from $646.96M to $1.04B.
- What is the long-term trend for CG Oncology's short-term investments?
- Over 2 years (2023 to 2025), CG Oncology's short-term investments has grown at a 98.9% compound annual growth rate (CAGR), from $179.41M to $709.67M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.